Bradley Foster & Sargent’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bradley Foster & Sargent’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-5,400	Closed	-$255K	–	346
2016 Q4	$255K	Hold	5,400	–	–	0.01%	311
2016 Q3	$269K	Hold	5,400	–	–	0.01%	307
2016 Q2	$260K	Hold	5,400	–	–	0.01%	300
2016 Q1	$247K	Sell	5,400 -180	-3%	-$8.42K	0.01%	298
2015 Q4	$301K	Buy	5,580 +180	+3%	+$9.47K	0.01%	277
2015 Q3	$266K	Hold	5,400	–	–	0.01%	297
2015 Q2	$315K	Hold	5,400	–	–	0.01%	298
2015 Q1	$310K	Hold	5,400	–	–	0.01%	300
2014 Q4	$273K	Hold	5,400	–	–	0.01%	299
2014 Q3	$253K	Sell	5,400 -975	-15%	-$44K	0.01%	317
2014 Q2	$287K	Sell	6,375 -300	-4%	-$12.9K	0.01%	295
2014 Q1	$282K	Hold	6,675	–	–	0.01%	295
2013 Q4	$263K	Sell	6,675 -1,125	-14%	-$42.2K	0.01%	313
2013 Q3	$277K	Buy	+7,800	New	+$275K	0.02%	294

Other funds holding IHE

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PAG

Pinnacle Advisory Group Columbia, Maryland $2.17B AUM 39.21% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Spinnaker Trust Portland, Maine $2.06B AUM 24.94% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

RTS

Round Table Services Westfield, New Jersey $508M AUM 16.36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bradley Foster & Sargent's IHE Position: Q1 2017 in Review

Bradley Foster & Sargent sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2017, closing a stake of 5,400 shares — an estimated $255K sold.

Bradley Foster & Sargent first reported a position in IHE in Q3 2013 and held it in 14 quarters. The position peaked at $315K in Q2 2015. 97 funds tracked by Wall St. Rank hold IHE as of Q1 2017.

Bradley Foster & Sargent reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2017 after selling out during the quarter.
Bradley Foster & Sargent sold 5,400 iShares US Pharmaceuticals ETF shares in Q1 2017, an estimated $255K.
Bradley Foster & Sargent first reported a position in iShares US Pharmaceuticals ETF in Q3 2013 and held it in 14 quarters.
Bradley Foster & Sargent's iShares US Pharmaceuticals ETF position peaked at $315K in Q2 2015.
97 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2017.

Based on Bradley Foster & Sargent's 13F filing for Q1 2017, filed 12 May 2017.